The "initial deadline" corresponds to day proposals are due at the Office of Grants and Contracts Administration (OGCA). OGCA deadlines are uniformly five (5) days before the official agency deadline. Remember to notify OGCA of your intent to submit.
The amount represents the "upper amount" listed for this opportunity.
For proposal development assistance, please contact the Research Development Office.
|
Initial Deadline
|
Title
|
Sponsor
|
Sub-Sponsor
|
Amount
|
| Open |
Support of NIGMS Program Project Grants (P01) |
NIH |
HHS, NIGMS |
$6,500,000 |
| Open |
Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01) |
NIH |
HHS |
$2,500,000 |
| Open |
Enhancing Zebrafish Research with Research Tools and Techniques (R01) |
NIH |
HHS |
$2,500,000 |
| Open |
Genetic Screens to Enhance Zebrafish Research (R01) |
NIH |
HHS |
$2,500,000 |
| Open |
Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01) |
NIH |
HHS, NIDA |
$6,000,000 |
| Open |
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Training for a Dental and Craniofacial Research Workforce (T32)
|
NIH |
HHS, NIDCR |
$4,000,000 |
| Open |
Collaborative Clinical Trials in Drug Abuse (Collaborative R01)
|
NIH |
HHS, NIDA |
$2,500,000 |
| Open |
Erythropoiesis: Components and Mechanisms (R01)
|
NIH |
HHS |
$2,500,000 |
| Open |
Innovations in Biomedical Computational Science and Technology (R01)
|
NIH |
HHS |
$2,500,000 |
| Open |
Competing Renewal Awards of SBIR Phase IIB GRants for Brain and Behavior Tools (R44)
|
NIH |
HHS |
$2,400,000 |
| Open |
Translational Programs in Lung Diseases (P01)
|
NIH |
HHS, NHLBI |
$8,750,000 |
| Open |
Ancillary Studies to Major Ongoing Clinical Research Studies to Advance Areas of Scientific Interest Within the Mission of the NIDDK (R01)
|
NIH |
HHS, NIDDK |
$2,500,000 |
| Open |
Image-Guided Drug Delivery in Cancer (R01)
|
NIH |
HHS, NCI |
$2,500,000 |
| Open |
Research on Teen Dating Violence (R01) |
NIH |
HHS |
$2,500,000 |
| Open |
Basic and Clinical Studies of Congenital Urinary Tract Obstruction (R01)
|
NIH |
HHS |
$2,500,000 |
| Open |
Grand Opportunity in Medications Development for Substance-Related Disorders (U01) - PAR-11-109 |
NIH |
HHS |
$15,000,000 |
| Open |
Erythropoiesis Components and Mechanisms (R01) |
NIH |
HHS |
$2,500,000 |
| Open |
Research on Teen Dating Violence (R01) |
NIH |
HHS |
$2,500,000 |
| Open |
Image-Guided Drug Delvery in Cancer (R01) |
NIH |
HHS, NCI |
$2,500,000 |
| Open |
Collaborative Clinical Trials in Drug Abuse (Collaborative R01) |
NIH |
HHS, NIDA |
$2,500,000 |
| Open |
Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01) |
NIH |
HHS, NCI |
$2,500,000 |
| Open |
Basic and Clinical Studies of Congenital Urinary Tract Obstruction (R01) |
NIH |
HHS |
$2,500,000 |
| Open |
Innovations in Biomedical Computational Science and Technology (R01) |
NIH |
HHS |
$2,500,000 |
